[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615451":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":19,"locations":20,"responsibleParty":39,"collaborators":19,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":19,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":19,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":19,"overallStatus":23,"whyStopped":19,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Samyang Biopharmaceuticals Corporation","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"DMFI150","EXPERIMENTAL","Single injection of DMFI150",[13],"Device: DMFI150",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Injection of DMFI150 for nasolabial folds.",[9],null,[21],{"facility":22,"status":23,"city":24,"state":19,"zip":19,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Ocean Clinic","RECRUITING","Marbella","Spain","ES",{"type":28,"coordinates":29},"Point",[30,31],-4.88583,36.51543,{"lat":31,"lon":30},[34],{"name":35,"role":36,"phone":37,"phoneExt":19,"email":38},"Vanessa","CONTACT","+34 951 775 518","admon@oceanclinic.net",{"type":40,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100615451","a-prospective-clinical-investigation-of-dmfi150-for-treating-nasolabial-folds-100615451",false,"NCT07292779","A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds","A Prospective, Clinical Investigation to Evaluate the Performance and Safety of DMFI150 for the Treatment of Nasolabial Folds","Inclusion Criteria:\n\n* Men and women aged 18-70 years.\n* Score of 3 to 4 on the WSRS (1 = absent, 2 = mild, 3 = moderate, 4 = severe, and 5 = extreme) for both nasolabial folds.\n* Able and willing to provide written informed consent.\n* Willing to refrain from facial cosmetic procedures during the study.\n\nExclusion Criteria:\n\n* Use of antiplatelet agents, vitamin E, or NSAIDs within 2 weeks before screening or 2 weeks after treatment.\n* History or current bleeding disorders.\n* Participation in another clinical trial within 1 month before screening.\n* Pregnant or breastfeeding women, or planning pregnancy.\n* Women of childbearing potential not using effective contraception.","ALL","18 Years","70 Years",{"count":52,"type":53},30,"ESTIMATED","INTERVENTIONAL",[56],"NA","This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.",[59],"Nasolabial Folds, Wrinkles","2026-03-04",{"date":62,"type":63},"2026-03-05","ACTUAL",{"date":65,"type":63},"2025-11-24",{"date":67,"type":53},"2026-12",{"name":5,"class":6},1]